Melanoma classification and management in the era of molecular medicine

Sarem Rashid1, Michael Shaughnessy2, Hensin Tsao3

  • 1Wellman Center for Photomedicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA; Boston University School of Medicine, Boston, MA 02118, USA.

Dermatologic Clinics
|November 21, 2022
PubMed

Insights

This review covers melanoma epidemiology and advances in screening, diagnosis, and treatment. It highlights how new therapies offer hope but face challenges like drug resistance.

Area of Science:

  • Dermatology
  • Oncology
  • Cancer Research

Background:

  • Melanoma is a lethal skin cancer, but early detection and treatment improve outcomes.
  • Advanced melanoma treatments like chemotherapy and immunotherapy show promise but face resistance.
  • Combination therapies are transforming melanoma treatment paradigms.

Purpose of the Study:

  • To review current melanoma epidemiology.
  • To discuss recent advancements in melanoma screening and diagnosis.
  • To summarize updated surgical and systemic treatment strategies.

Main Methods:

  • Literature review of melanoma epidemiology.
  • Analysis of recent advancements in screening and histopathological classification.
  • Review of staged excision techniques (wide local excision, sentinel lymph node biopsy, Mohs surgery).
  • Evaluation of current systemic treatments including chemotherapy, targeted therapy, and immunotherapy.

Main Results:

  • Melanoma incidence and mortality rates.
  • Effectiveness of early screening and prevention strategies.
  • Clinical outcomes and limitations of current systemic therapies.
  • Impact of combination therapies on melanoma treatment.

Conclusions:

  • Early detection and prevention remain crucial for melanoma management.
  • Systemic therapies have improved outcomes but resistance is a significant challenge.
  • Ongoing research into novel treatments and combination therapies is vital for advancing melanoma care.

Related Concept Videos

Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.4K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.0K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K